Could cause temporary or reversible harm; serious harm is unlikely.
Failed Stability Specifications: Out-of-specification test result for water content obtained during routine stability testing.
| Distributed by / for | Teva Pharmaceuticals USA |
| NDC | 0555-0098-96 |
| Full product label | Clonazepam Orally Disintegrating Tablets USP, 2 mg., 60-count carton. RX only. Teva Pharmaceuticals USA, INC. North Whales, PA 19454. NDC 0555-0098-96 |
| Recalling firm | Teva Pharmaceuticals USA |
| Distribution | Product was distributed throughout the United States to various distributors who may have further distributed the product. |
| Quantity | 1,373 60-count cartons |
| Recall initiated | 2018-09-20 |
| Report date | 2018-10-24 |
| Recall completed | 2019-11-07 |
| Recall number | D-0082-2019 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | North Wales PA United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗